FDA panel backs Amgen drug for blood disorder (Reuters)Reuters - A U.S. advisory panel
unanimously urged regulators Wednesday to approve an Amgen drug
for a rare blood disorder that puts patients at risk of serious
bleeding.
http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/amgen_drug_blood_dc.html